George Sledge responds to Berry’s letter: Neoadjuvant doesn’t predict adjuvant in breast cancer and Berry’s rejoinder July 11, 2014Vol.40 No.28By George W. Sledge Jr. and Donald A. Berry
Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant July 11, 2014Vol.40 No.28By Donald A. Berry
NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants July 11, 2014Vol.40 No.28By Paul Goldberg and Will Craft
Free BSA Approves Trial of Carbon Ion Therapy, Extends EDRN and Provocative Questions July 03, 2014Vol.40 No.27By Tessa Vellek and Will Craft
Conversation with The Cancer LetterFree Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside of a Registry Trial July 03, 2014Vol.40 No.27By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Challoner: We Recommended FDA Replace 510(k) Clearance July 03, 2014Vol.40 No.27By Matthew Bin Han Ong
Free Harvard Physician Whose Cancer Was Spread Through Morcellation Seeks to Revamp FDA Regulation of Medical Devices 2 July 03, 2014Vol.40 No.27
Free Harvard Physician Whose Cancer Was Spread Through Morcellation Seeks to Revamp FDA Regulation of Medical Devices July 03, 2014Vol.40 No.27By Matthew Bin Han Ong
